Iodine contrast media doses equal-attenuating with gadolinium chelates at CT-aortography may have less risk of contrast-induced nephropathy and no risk of nephrogenic systemic fibrosis in azotaemic patients!

Author： Nyman Ulf  

Publisher： Springer Publishing Company

ISSN： 0938-7994

Source： European Radiology, Vol.18, Iss.9, 2008-09, pp. : 2013-2014

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

ESUR guideline: gadolinium-based contrast media and nephrogenic systemic fibrosis

By Thomsen Henrik  

European Radiology, Vol. 17, Iss. 10, 2007-10 ,pp. : 2692-2696

Springer Publishing Company

Access to resources Recommend Favorite

Enhanced Computed Tomography or Magnetic Resonance Imaging: A Choice between Contrast Medium-Induced Nephropathy and Nephrogenic Systemic Fibrosis?

By Thomsen H. S.   Marckmann P.   Logager V. B.  

Acta Radiologica, Vol. 48, Iss. 6, 2007-01 ,pp. : 593-596

Blackwell Publishing

Access to resources Recommend Favorite

Gadolinium-based contrast media may be nephrotoxic even at approved doses

By Thomsen Henrik  

European Radiology, Vol. 14, Iss. 9, 2004-09 ,pp. : 1654-1656

Springer Publishing Company

Access to resources Recommend Favorite

Effects of Gadolinium Contrast Agents in Naive and Nephrectomized Rats: Relevance to Nephrogenic Systemic Fibrosis

By Grant D.   Johnsen H.   Juelsrud A.   Løvhaug D.  

Acta Radiologica, Vol. 50, Iss. 2, 2009-01 ,pp. : 156-169

Blackwell Publishing

Access to resources Recommend Favorite

Risk of contrast-medium-induced nephropathy in high-risk patients undergoing MDCT - A pooled analysis of two randomized trials

By Thomsen Henrik  

European Radiology, Vol. 19, Iss. 4, 2009-04 ,pp. : 891-897

Springer Publishing Company

Access to resources Recommend Favorite